Mechanism could provide low-income countries with early access to COVID-19 vaccines
Vaccine could be in use in Britain by September
Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility
As part of the deal, Merus could receive a total of up to around $1.6bn for three products
Investigational PD-1 inhibitor is being studied in mismatch repair-deficient solid tumours
Announcement comes as ten new vaccination centres open in England
Test can identify cases of ‘ventilator-associated pneumonia’
'Temporary' reduction comes as companies bolster production capacity for the year
Companies will collaborate on novel drugs for autoimmune disorders
PME interviews integrated medhealth communication (imc) group's President and CEO
PME interviews Havas Life Medicom's Managing Partner
PME interviews Rubica's Director of Culture & Engagement
Protection after infection lasts for at least five months on average
Pharmacies will join the effort to bolster the UK’s mass vaccination rollout
Additional option extends dosing from two weeks to four weeks
FDA priority review is based on data from the phase 3 FIDELIO-DKD trial
Collaboration will utilise KSQ’s CRISPR-screening technology
Patients treated with mAb recovered 3.4 to 6.4 days quicker compared to placebo
Chief scientific officer Paul Stoffels said J&J is aiming for one billion doses in 2021
Osborne has previously worked at Ipsos and IQVIA
Karen Urban joins Evoke as a vice president
Eileen Gallagher and Karine Henderson take on new leadership roles
Dan Bridges is appointed as new chief executive officer
Dugan has spent over a decade at Publicis Health
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...